7-Deaza-7-iodo-2'-deoxyadenosine is a chemically modified nucleoside analog. Its structure features a deaza modification at the 7-position of the adenine base, where a carbon atom replaces the nitrogen, and an iodine atom is introduced at that same 7-position. The sugar moiety is 2'-deoxyribose. This specific modification alters the hydrogen bonding and electronic properties of the nucleobase. This compound serves as a crucial intermediate in the synthesis of nucleoside-based therapeutics and research probes. It is notably used in the preparation of 7-deaza-2'-deoxyadenosine triphosphate (7-deaza-dATP), a nucleotide analog utilized in DNA sequencing applications to minimize band compressions caused by secondary structures in GC-rich regions. Its iodine atom provides a versatile handle for further functionalization via cross-coupling reactions, such as the Sonogashira reaction, enabling the attachment of fluorescent tags or other functional groups for creating advanced molecular tools. As a modified nucleoside, it falls under the category of life science reagents and building blocks for nucleic acid chemistry. Its primary value lies in research and development for molecular biology, diagnostics, and the exploration of novel antiviral or anticancer agents that target nucleic acid metabolism.